Riolan弓直径与孤立性肠系膜上动脉夹层治疗选择的相关性
回顾性纳入95例CTA确诊的孤立性肠系膜上动脉夹层(ISMAD)患者及95例腹部CTA无阳性发现对照,测量Riolan弓直径(DR)。ISMAD组Riolan弓出现率及DR显著高于对照组;侵入性治疗组基线DR及高风险夹层比例更高。DR和Li分型是治疗选择的独立危险因素,DR cutoff 2.635 mm时AUC 0.805、敏感度0.778、特异度0.794。
要点
- ISMAD患者Riolan弓出现率及直径显著高于无病变对照。
- 基线Riolan弓直径较大者更可能接受侵入性治疗。
- DR cutoff 2.635 mm对治疗选择有中等预测效能(AUC 0.805)。
关键影像表现/征象
- ISMAD组Riolan弓出现率为83.16%,显著高于对照组的35.79%(P < 0.001)。
- ISMAD组Riolan弓直径为2.63 ± 0.56 mm,显著大于对照组的2.12 ± 0.39 mm(P < 0.001)。
- 侵入性治疗组基线Riolan弓直径为2.93 ± 0.57 mm,显著高于保守治疗组的1.89 ± 1.14 mm(P < 0.001)。
- 侵入性治疗组高风险夹层比例显著高于保守治疗组(P < 0.001)。
诊断标准与关键数值
- 二元logistic回归显示Riolan弓直径(OR = 2.771,95% CI 1.157-6.638,P = 0.022)和Li分型(OR = 0.107,95% CI 0.019-0.586,P = 0.010)是治疗选择的独立危险因素。
- 以2.635 mm为cutoff值,Riolan弓直径预测治疗选择的AUC为0.805,敏感度0.778,特异度0.794。
临床应用与阅片要点
- 在ISMAD患者CTA阅片时,应关注并测量Riolan弓直径,辅助评估疾病严重程度及治疗倾向。
- Riolan弓直径≥2.635 mm提示侵入性治疗可能性较高,可作为报告中的参考信息。
- 结合Li分型综合判断,高风险夹层类型与侵入性治疗相关。
局限性
- 回顾性单中心研究,样本量有限,结论需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the diameter changes of Riolan's arch in patients with isolated superior mesenteric artery dissection (ISMAD) and to evaluate the implication for treatment selection.
METHODS: Ninety-five patients with CT angiography (CTA) confirmed ISMAD were retrospectively included, and another 95 cases with no positive findings on abdominal CTA were included as controls. According to the treatment methods, the patients were subsequently divided into conservative treatment (n = 68) or invasive treatment (n = 27) subgroups. According to the initial CTA images, the prevalence of Riolan's arch as well as its diameter (DR) were determined in each subject, and compared between ISMAD and control cases, as well as between patients with different treatments. In patients with ISMAD, dissections were classified according to the Li classification.
RESULTS: Riolan's arch prevalence and DR were significantly elevated in the ISMAD group compared with the control group (83.16% vs. 35.79%, P < 0.001; 2.63 ± 0.56 mm vs. 2.12 ± 0.39 mm, P < 0.001). Patients with invasive treatment had significantly higher baseline DR (2.93 ± 0.57 mm vs. 1.89 ± 1.14 mm, P < 0.001), and higher proportion of high-risk dissection (P < 0.001) than those administered conservative treatment. Binary logistic regression revealed DR (OR = 2.771, 95% CI 1.157-6.638, P = 0.022) and Li classification (OR = 0.107, 95% CI 0.019-0.586, P = 0.010) were independent risk factors for treatment selection. With cutoff of 2.635 mm, the area under the curve, sensitivity, and specificity were 0.805, 0.778 and 0.794, respectively.
CONCLUSION: Dilation of Riolan's arch is common in patients with ISMAD, and Riolan's arch diameter could be a convenient indicator of disease severity and inform subsequent treatment.
引用
- Peng, Li, Tang, et al. Correlation of Riolan's arch diameter to treatment choice in patients with isolated superior mesenteric artery dissection. Abdom Radiol (NY). 2022. PMID: 35913506. doi:10.1007/s00261-022-03622-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。